Dygnostica
(TRUHELTH DIAGNOSTICS PRIVATE LIMITED)
Founded in 2017
About Dygnostica
Truhelth Diagnostics Private Limited is a healthcare and diagnostics solutions provider focusing on the screening, prevention, and monitoring of non-communicable diseases such as diabetes, cardiovascular conditions, and cancer. They are currently developing innovative at-home solutions to make healthcare more accessible.
Key Focus Areas of Dygnostica
Healthcare & Diagnostic SolutionsIncubators & Accelerators of Dygnostica
Public Links of Dygnostica
Frequently Asked Questions (FAQ)
When was Dygnostica founded?
Dygnostica was founded in the year 2017.
What is the legal name of Dygnostica?
The legal name of Dygnostica is Truhelth Diagnostics Private Limited.
Who are the founders of Dygnostica?
Dygnostica is founded by Rajendra Kumar Charan and Vijay Jethalal Jogadia.
Which Incubators & Accelerators supported Dygnostica?
What are the focus areas of Dygnostica?
Who are Dygnostica's competitors?
Possible competitors of Dygnostica may include Exocan Healthcare Technologies, Erlysign, Fluorogent Analytics and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
